Perjeta

(pertuzumab)
14 ML pertuzumab 30 MG/ML Injection [Perjeta]

Dosage & administration

eficacy, safety & testing

Perjeta clinical details

Mechanism of Action
Clinical Trial: Neoadjuvant
Safety Profile: Neoadjuvant
Dosing: Neoadjuvant
Clinical Trial: Adjuvant
Efficacy: Adjuvant
Safety Profile: Adjuvant
Dosing: Adjuvant
Clinical Trial: Metastatic
Efficacy: Metastatic
Efficacy: Neoadjuvant
Safety Profile: Metastatic
Dosing: Metastatic

drug label

Perjeta prescribing information

Have more Perjeta questions?

Submit MSL Request
Learn More

Need to report a Perjeta issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Perjeta Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request
Coverage Authorization Appeals
Learn More

Benefits investigation

Prescriber Service Form - Online Portal
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Perjeta Financial assistance options

Co-pay savings program

commercial only
Prescriber Service Form - Online Portal
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Prescriber Service Form - Online Portal
Genentech Patient Foundation Application Form - Prescriber Form
Learn More

patient education

Perjeta Patient education

Getting started on Perjeta

NOT PROVIDED BY BRAND
Instructions For Use: Metastatic Breast Cancer

NOT PROVIDED BY BRAND
Instructions For Use: Early Breast Cancer (Neoadjuvant)

NOT PROVIDED BY BRAND
Instructions For Use: Early Breast Cancer (Adjuvant)

Patient toolkit

About Perjeta
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Early Breast Cancer Treatment
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Perjeta: Early Breast Cancer Treatment Before Surgery (Neoadjuvant)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Perjeta: Early Breast Cancer Treatment After Surgery (Adjuvant)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Perjeta: Early Breast Cancer (Neoadjuvant & Adjuvant)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Perjeta: Metastatic Breast Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Perjeta: Metastatic Breast Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Discussion Guide - Early Breast Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Discussion Guide - Metastatic Breast Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure - Early Breast Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure - Metastatic Breast Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Perjeta FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.